Amgen confirms potential all-cash offer for Horizon Therapeutics

AMGEN INC

Amgen states any offer for Horizon will be solely in cash.
No certainty that a formal offer will be made; further updates expected.
Disclosure follows Horizon's Rule 2.4 announcement; made under Irish Takeover Rules.

item 7.01 item 9.01

AMGEN INC filing history →

Source: SEC EDGAR

accession 0001193125-22-297131

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.